B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE-2 RESULTS. (5th April 2022)

Record Type:
Journal Article
Title:
B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE-2 RESULTS. (5th April 2022)
Main Title:
B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE-2 RESULTS
Authors:
van de Donk, NWCJ
Delforge, M
Agha, M
Cohen, AD
Cohen, YC
Hillengass, J
Anguille, S
Kerre, T
Roeloffzen, W
Schecter, JM
De Braganca, KC
Varsos, H
Wang, L
Vogel, M
Zudaire, E
Corsale, C
Akram, M
Geng, D
Nesheiwat, T
Pacaud, L
Sonneveld, P
Zweegman, S
Abstract:
Is Part Of:
HemaSphere. Volume 6(2022)Supplement 2
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 2
Issue Display:
Volume 6, Issue 2 (2022)
Year:
2022
Volume:
6
Issue:
2
Issue Sort Value:
2022-0006-0002-0000
Page Start:
9
Page End:
10
Publication Date:
2022-04-05
Subjects:
Hematology -- Periodicals
616.15005
Journal URLs:
https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1097/01.HS9.0000829568.10814.bc ↗
Languages:
English
ISSNs:
2572-9241
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
21663.xml